BCG‐induced cytokine release in bladder cancer cells is regulated by Ca 2+ signaling
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
BCG‐induced cytokine release in bladder cancer cells is regulated by Ca
2+
signaling
Authors
Keywords
-
Journal
Molecular Oncology
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2018-10-25
DOI
10.1002/1878-0261.12397
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Epithelial-mesenchymal transition in cancer: Role of the IL-8/IL-8R axis
- (2017) Zhiwei Zhao et al. Oncology Letters
- Non-muscle-invasive bladder cancer: Intravesical treatments beyond Bacille Calmette-Guérin
- (2016) Vignesh T. Packiam et al. CANCER
- Cytokine Panel for Response to Intravesical Therapy (CyPRIT): Nomogram of Changes in Urinary Cytokine Levels Predicts Patient Response to Bacillus Calmette-Guérin
- (2016) Ashish M. Kamat et al. EUROPEAN UROLOGY
- Diagnosis and Treatment of Non-Muscle Invasive Bladder Cancer: AUA/SUO Guideline
- (2016) Sam S. Chang et al. JOURNAL OF UROLOGY
- Toll-like receptor 9 protects non-immune cells from stress by modulating mitochondrial ATP synthesis through the inhibition of SERCA2
- (2014) Y. Shintani et al. EMBO REPORTS
- The mechanism of action of BCG therapy for bladder cancer—a current perspective
- (2014) Gil Redelman-Sidi et al. Nature Reviews Urology
- Frequency decoding of calcium oscillations
- (2013) Erik Smedler et al. BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS
- TLR9 mediates cellular protection by modulating energy metabolism in cardiomyocytes and neurons
- (2013) Y. Shintani et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The IL-8-Regulated Chemokine Receptor CXCR7 Stimulates EGFR Signaling to Promote Prostate Cancer Growth
- (2011) R. K. Singh et al. CANCER RESEARCH
- Biochemistry of calcium oscillations
- (2010) Per Uhlén et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Changes in urinary cytokines and soluble intercellular adhesion molecule-1 (ICAM-1) in bladder cancer patients after Bacillus Calmette-Guérin (BCG) immunotherapy
- (2010) A. M. JACKSON et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Modeling oscillatory control in NF-κB, p53 and Wnt signaling
- (2010) Benedicte Mengel et al. CURRENT OPINION IN GENETICS & DEVELOPMENT
- Recombinant bacillus Calmette-Guérin (BCG) expressing interferon-alpha 2B enhances human mononuclear cell cytotoxicity against bladder cancer cell lines in vitro
- (2009) Wujiang Liu et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Curcumin Potentiates the Antitumor Effects of Bacillus Calmette-Guerin against Bladder Cancer through the Downregulation of NF- B and Upregulation of TRAIL Receptors
- (2009) A. M. Kamat et al. CANCER RESEARCH
- Bacillus Calmette–Guerin immunotherapy for urothelial carcinoma of the bladder
- (2009) Timothy P Kresowik et al. Immunotherapy
- Bladder cancer
- (2009) Donald S Kaufman et al. LANCET
- Immunomodulatory effects of recombinant BCG expressing pertussis toxin on TNF-alpha and IL-10 in a bladder cancer model
- (2008) Daher C Chade et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Role of neutrophils in BCG immunotherapy for bladder cancer
- (2008) Mark P. Simons et al. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started